Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence.
Morales Barroso I, López-Cerero L, Navarro MD, Gutiérrez-Gutiérrez B, Pascual A, Rodríguez-Baño J. Morales Barroso I, et al. Among authors: navarro md. Antimicrob Resist Infect Control. 2018 Nov 15;7:135. doi: 10.1186/s13756-018-0427-9. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 30473785 Free PMC article.
Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR, Pascual A. Rodríguez-Baño J, et al. Among authors: navarro md. Clin Infect Dis. 2006 Jan 1;42(1):37-45. doi: 10.1086/498519. Epub 2005 Nov 29. Clin Infect Dis. 2006. PMID: 16323089 Free article.
Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.
López-Cerero L, Navarro MD, Bellido M, Martín-Peña A, Viñas L, Cisneros JM, Gómez-Langley SL, Sánchez-Monteseirín H, Morales I, Pascual A, Rodríguez-Baño J. López-Cerero L, et al. Among authors: navarro md. J Antimicrob Chemother. 2014 Mar;69(3):809-14. doi: 10.1093/jac/dkt405. Epub 2013 Oct 11. J Antimicrob Chemother. 2014. PMID: 24123431
Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
Morales-Barroso I, López-Cerero L, Molina J, Bellido M, Navarro MD, Serrano L, González-Galán V, Praena J, Pascual A, Rodríguez-Baño J. Morales-Barroso I, et al. Among authors: navarro md. Int J Antimicrob Agents. 2017 Apr;49(4):498-502. doi: 10.1016/j.ijantimicag.2016.12.013. Epub 2017 Feb 28. Int J Antimicrob Agents. 2017. PMID: 28257756
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.
Rodríguez-Baño J, Picón E, Navarro MD, López-Cerero L, Pascual A; ESBL-REIPI Group. Rodríguez-Baño J, et al. Among authors: navarro md. Clin Microbiol Infect. 2012 Sep;18(9):894-900. doi: 10.1111/j.1469-0691.2011.03673.x. Epub 2011 Oct 10. Clin Microbiol Infect. 2012. PMID: 21985560 Free article.
130 results